Literature DB >> 11711166

Cognitive functioning in stabilized first-episode psychosis patients.

L A Townsend1, A K Malla, R M Norman.   

Abstract

This paper describes the cognitive functioning of a community cohort of individuals presenting with a first episode of a schizophrenia spectrum psychosis. Data were obtained for 107 patients (mean age 25 years) following stabilization of acute psychotic symptoms, mostly with the use of novel antipsychotics, on measures of intellectual, memory, attentional and executive functioning using a standardized battery of cognitive measures, including WAIS III and WMS III. While patients generally performed in the average range across the majority of measures, deficits (Z-scores >1.0 S.D.) were observed on measures of speed of information processing (PASAT, WAIS III) and executive functions (Stroop Test and Trails B), with the greatest deficits observed on tests of processing speed (PASAT). Discrepancy scores between the NART and the WAIS suggest subtle but statistically significant declines in full scale and performance IQ following onset of psychosis. Differences in cognitive functioning between diagnostic groups were not supported. Comparison of the highest and lowest functioning patients with respect to the cognitive measures also did not support any demographic or clinical differences between these two subgroups. Our results suggest a relatively benign cognitive profile in first-episode schizophrenia spectrum psychosis, regardless of diagnosis, when most potential incidence cases in the community are included. The most severe deficits reported were on measures of speeded information processing, and level of performance did not distinguish between patients demographically or clinically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711166     DOI: 10.1016/s0165-1781(01)00302-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

1.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

Review 2.  Psychomotor slowing in schizophrenia.

Authors:  Manuel Morrens; Wouter Hulstijn; Bernard Sabbe
Journal:  Schizophr Bull       Date:  2006-11-08       Impact factor: 9.306

Review 3.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

4.  Gait control and executive dysfunction in early schizophrenia.

Authors:  Elise Lallart; Roland Jouvent; François R Herrmann; Fernando Perez-Diaz; Xavier Lallart; Olivier Beauchet; Gilles Allali
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

Review 5.  Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.

Authors:  Louis S Matza; Robert Buchanan; Scot Purdon; Jessica Brewster-Jordan; Yang Zhao; Dennis A Revicki
Journal:  Schizophr Bull       Date:  2006-07-07       Impact factor: 9.306

6.  Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns.

Authors:  César González-Blanch; Mario Alvarez-Jiménez; José Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; José Luis Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

Review 7.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

8.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Apathy and the processing of novelty in schizophrenia.

Authors:  Robert M Roth; Nancy S Koven; Jo Cara Pendergrass; Laura A Flashman; Thomas W McAllister; Andrew J Saykin
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

Review 10.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.